The stock of Cronos Group Inc. (NASDAQ:CRON) reached all time high today, Jan, 27 and still has $17.30 target or 8.00 % above today’s $16.02 share price. This indicates more upside for the $2.86 billion company. This technical setup was reported by Barchart.com. If the $17.30 PT is reached, the company will be worth $228.48 million more.
Trading stocks at an all time highs is usually a winning strategy. An all time high points to a stock which has the most positive fundamentals ever. Even thought the pullback rate is high, if correct risk management is utilized, investors can trade very well such events.

The stock increased 2.04% or $0.32 during the last trading session, reaching $16.02. About 14.67 million shares traded or 48.51% up from the average. Cronos Group Inc. (NASDAQ:CRON) has risen 277.71% since January 27, 2018 and is uptrending. It has outperformed by 277.71% the S&P500.

Analysts await Cronos Group Inc. (NASDAQ:CRON) to report earnings on April, 29. They expect $-0.01 EPS, down 200.00 % or $0.02 from last year’s $0.01 per share. After $-0.03 actual EPS reported by Cronos Group Inc. for the previous quarter, Wall Street now forecasts -66.67 % EPS growth.

More notable recent Cronos Group Inc. (NASDAQ:CRON) news were published by: Fool.com which released: “Altria Aims to Start 2019 Strong – The Motley Fool” on January 26, 2019, also Nasdaq.comwith their article: “Cronos Group (CRON) Stock Sinks As Market Gains: What You Should Know – Nasdaq” published on January 08, 2019, Nasdaq.com published: “Why Cronos Group Stock Jumped 14% in December While Other Marijuana Stocks Plunged – Nasdaq” on January 07, 2019. More interesting news about Cronos Group Inc. (NASDAQ:CRON) were released by: Fool.com and their article: “Why Cronos Group Stock Gained 34.4% in 2018 – The Motley Fool” published on January 14, 2019 as well as Fool.com‘s news article titled: “2 Marijuana Stocks Wall Street Thinks Will Drop – Motley Fool” with publication date: January 22, 2019.

Cronos Group Inc., formerly known as PharmaCan Capital Corp., is a principal investment firm. The company has market cap of $2.86 billion. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations . It currently has negative earnings. The firm typically invests in companies based in Canada.